Peng-Sheng Yi

  • Citations Per Year
Learn More
BACKGROUND To assess the efficacy and safety of alvimopan in conjunction with enhanced recovery strategy, compared with this strategy alone, in management of postoperative ileus in patients undergoing open abdominal surgery. METHODS Electronic databases were comprehensively searched for relevant randomized controlled trials. We were interested in doses of(More)
Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the augmented growth and metastasis of residual HCC induced by(More)
BACKGROUND Liver regeneration is a complex process. microRNAs (miRNAs) are short, single-stranded RNAs that modify gene expression at the post-transcriptional level. Recent investigations have revealed that miRNAs are closely linked to liver regeneration. DATA SOURCES All included studies were obtained from PubMed, Embase, the ScienceDirect databases and(More)
Background: Sorafenib is the first systemic therapy approved for hepatocellular carcinoma (HCC), but its efficacy and safety for unresectable HCC remain controversial. Methods: We searched for randomized controlled trials (RCTs) about sorafenib treatment in unresectable HCC in Web of Science, Embase, PubMed, and the Cochrane Library. Critical outcomes(More)
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. The Barcelona Clinic Liver Cancer (BCLC) staging system is regarded as the gold standard staging system for HCC, classifying HCC as early, intermediate, or advanced. For intermediate HCC, trans-catheter arterial chemoembolization (TACE) is recommended as the optimal strategy(More)
  • 1